These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combined androgen blockade: the gold standard for metastatic prostate cancer. McLeod DG; Crawford ED; DeAntoni EP Eur Urol; 1997; 32 Suppl 3():70-7. PubMed ID: 9267789 [TBL] [Abstract][Full Text] [Related]
4. [Management of a hormone dependent cancer with endocrine therapy--prostate cancer]. Tsukamoto S; Akaza H Gan To Kagaku Ryoho; 2001 Jul; 28(7):917-26. PubMed ID: 11478140 [TBL] [Abstract][Full Text] [Related]
5. Endocrine therapy for prostate cancer. Damber JE Acta Oncol; 2005; 44(6):605-9. PubMed ID: 16165920 [TBL] [Abstract][Full Text] [Related]
6. [Maximal androgen blockade in the treatment of patients with disseminated cancer of the prostate]. Matveev BP; Bukharkin BV Vopr Onkol; 1998; 44(5):537-40. PubMed ID: 9884710 [TBL] [Abstract][Full Text] [Related]
9. [First line therapy in the treatment of metastatic prostate cancer]. Sakai H; Kanetake H Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704 [TBL] [Abstract][Full Text] [Related]
10. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR; Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313 [TBL] [Abstract][Full Text] [Related]
11. Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group. Calais da Silva FE; Bono AV; Whelan P; Brausi M; Marques Queimadelos A; Martin JA; Kirkali Z; Calais da Silva FM; Robertson C Eur Urol; 2009 Jun; 55(6):1269-77. PubMed ID: 19249153 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in hormonal therapy for advanced prostate cancer. Oottamasathien S; Crawford ED Oncology (Williston Park); 2003 Aug; 17(8):1047-52; discussion 1054-8. PubMed ID: 12966672 [TBL] [Abstract][Full Text] [Related]
17. Secondary hormonal therapy. Smith DC Semin Urol Oncol; 1997 Feb; 15(1):3-12. PubMed ID: 9050134 [TBL] [Abstract][Full Text] [Related]
18. Medical therapy of prostate cancer: 1999. Afrin LB; Ergul SM J S C Med Assoc; 2000 Feb; 96(2):77-84. PubMed ID: 10710906 [TBL] [Abstract][Full Text] [Related]
20. Luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer: a review of their discovery, development, and place in therapy. Moreau JP; Delavault P; Blumberg J Clin Ther; 2006 Oct; 28(10):1485-508. PubMed ID: 17157109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]